Cargando…

Inhibition of Angiogenesis by Interleukin 4

Interleukin (IL)-4, a crucial modulator of the immune system and an active antitumor agent, is also a potent inhibitor of angiogenesis. When incorporated at concentrations of 10 ng/ml or more into pellets implanted into the rat cornea or when delivered systemically to the mouse by intraperitoneal in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Volpert, Olga V., Fong, Tim, Koch, Alisa E., Peterson, Jeffrey D., Waltenbaugh, Carl, Tepper, Robert I., Bouck, Noël P.
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 1998
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212547/ https://www.ncbi.nlm.nih.gov/pubmed/9743522

Ejemplares similares

Nuclear Factor of Activated T Cells Balances Angiogenesis Activation and Inhibition
por: Zaichuk, Tetiana A., et al.
Publicado: (2004)

P-selectin, an important mediator of angiogenesis in females: the role of estradiol
por: Koch, AE, et al.
Publicado: (2004)

Therapeutic manipulation of angiogenesis with miR-27b
por: Veliceasa, Dorina, et al.
Publicado: (2015)

NK4 therapy: a new approach to target angiogenesis and inflammation in rheumatoid arthritis
por: Rabquer, Bradley J, et al.
Publicado: (2013)

Angiogenesis in rheumatoid arthritis: the role of fut 1
por: Koch, Alisa Erika
Publicado: (2012)

Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma
Publicado: (1994)

Interleukin‐33 regulates tissue remodelling and inhibits angiogenesis in the eye
por: Theodoropoulou, Sofia, et al.
Publicado: (2016)

Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer
por: Gong, Zhenqiang, et al.
Publicado: (2018)

Selective Inhibition of Vascular Endothelial Growth Factor–Mediated Angiogenesis by Cyclosporin a: Roles of the Nuclear Factor of Activated T Cells and Cyclooxygenase 2
por: Hernández, Gabriela L., et al.
Publicado: (2001)

Challenging the Paradigm: Anti-Inflammatory Interleukins and Angiogenesis
por: Peluzzo, Amanda M., et al.
Publicado: (2022)

Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis
por: Koch, Alisa E, et al.
Publicado: (2007)

Interleukin-2 and histamine in combination inhibit tumour growth and angiogenesis in malignant glioma
por: Johansson, M, et al.
Publicado: (2000)

Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour–stroma interaction
por: Nagasaki, T, et al.
Publicado: (2014)

miR-200b Inhibits Prostate Cancer EMT, Growth and Metastasis
por: Williams, LaTanya V., et al.
Publicado: (2013)

Chemopreventive apigenin controls UVB-induced cutaneous proliferation and angiogenesis through HuR and thrombospondin-1
por: Tong, Xin, et al.
Publicado: (2014)

The Role of Interleukin 17 in Tumour Proliferation, Angiogenesis, and Metastasis
por: Yang, Bob, et al.
Publicado: (2014)

Blocking the janus-activated kinase pathway reduces tumor necrosis factor alpha-induced interleukin-18 bioactivity by caspase-1 inhibition
por: Marotte, Hubert, et al.
Publicado: (2014)

Inhibition of angiogenesis by platelets in systemic sclerosis patients
por: Hirigoyen, Daniela, et al.
Publicado: (2015)

Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer
por: Ge, Guanqun, et al.
Publicado: (2016)

Interleukin-18 as an in vivo mediator of monocyte recruitment in rodent models of rheumatoid arthritis
por: Ruth, Jeffrey H, et al.
Publicado: (2010)

Apigenin Inhibits UVB-Induced Skin Carcinogenesis: The Role of Thrombospondin-1 as an Anti-Inflammatory Factor
por: Mirzoeva, Salida, et al.
Publicado: (2018)

Traveling wave solutions of parabolic systems
por: Volpert, Aizik I, et al.
Publicado: (1994)

Mathematical Modeling of Interleukin-35 Promoting Tumor Growth and Angiogenesis
por: Liao, Kang-Ling, et al.
Publicado: (2014)

Interleukin 37 promotes angiogenesis through TGF-β signaling
por: Zhao, Mengmeng, et al.
Publicado: (2017)

Macrophage-derived interleukin-6 is necessary and sufficient for choroidal angiogenesis
por: Droho, Steven, et al.
Publicado: (2021)

Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease(): III. Failure of neuroantigen-specific immune tolerance to affect the clinical course of demyelination
por: Miller, Stephen D., et al.
Publicado: (1990)

Interleukin-35 Is Involved in Angiogenesis/Bone Remodeling Coupling Through T Helper 17/Interleukin-17 Axis
por: Zhang, Hui, et al.
Publicado: (2021)

A unique role for galectin-9 in angiogenesis and inflammatory arthritis
por: O’Brien, Martin J., et al.
Publicado: (2018)

The Effect of Interleukin 38 on Angiogenesis in a Model of Oxygen-induced Retinopathy
por: Zhang, Jing, et al.
Publicado: (2017)

Interleukin-6 released by oral lichen planus myofibroblasts promotes angiogenesis
por: Xu, Xiao-Heng, et al.
Publicado: (2021)

Fucosyltransferase 1 mediates angiogenesis, cell adhesion and rheumatoid arthritis synovial tissue fibroblast proliferation
por: Isozaki, Takeo, et al.
Publicado: (2014)

Inhibition of human macrophage colony formation by interleukin 4
Publicado: (1989)

RNA‐binding protein SAMD4A inhibits breast tumor angiogenesis by modulating the balance of angiogenesis program
por: Zhou, Meicen, et al.
Publicado: (2021)

Thromboembolic risk with gender-affirming hormone therapy: potential role of global coagulation and fibrinolysis assays
por: Bouck, Emma G., et al.
Publicado: (2023)

Perivascular cell-specific knockout of the stem cell pluripotency gene Oct4 inhibits angiogenesis
por: Hess, Daniel L., et al.
Publicado: (2019)

Interleukin 4 inhibits the proliferation but not the differentiation of activated human B cells in response to interleukin 2
Publicado: (1988)

Genetic control of specific immune suppression. IV. Responsiveness to the random copolymer L-glutamic acid(50)-L-tyrosine(50) induced in BALB/c mice by cyclophosphamide
por: Debre, P, et al.
Publicado: (1976)

Genetic control of specific immune suppression. III. Mapping of H-2 complex complementing genes controlling immune suppression by the random copolymer L-glutamic acid(50)-L-Tyrosine(50) (GT)
por: Debre, P, et al.
Publicado: (1976)

Immunosuppressive factor(s) specific for L-glutamic acid(50)-L- tyrosine(50) (GT). II. Presence of I-J determinants on the GT-suppressive factor
por: Theze, J, et al.
Publicado: (1977)

Thalidomide inhibits inflammation and angiogenesis in tumor 4T1 growth in mice
por: Souza, Cristina M, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hclb6kihu2uai08eajlfsb4nkn